• Medicine · May 2016

    Observational Study

    Depression and Insomnia in Patients With Psoriasis and Psoriatic Arthritis Taking Tumor Necrosis Factor Antagonists.

    • Chun-Ying Wu, Yun-Ting Chang, Chao-Kuei Juan, Jui-Lung Shen, Yu-Pu Lin, Jeng-Jer Shieh, Han-Nan Liu, and Yi-Ju Chen.
    • From the Faculty of Medicine and Graduate Institute of Clinical Medicine (C-YW, Y-TC, Y-PL, Y-JC), National Yang-Ming University, Taipei; Division of Gastroenterology (C-YW), Taichung Veterans General Hospital; Department of Public Health and Graduate Institute of Clinical Medical Sciences (C-YW), China Medical University; Department of Life Sciences and RongHsing Research Center for Translational Medicine (C-YW), National Chung-Hsing University, Taichung; Department of Dermatology (Y-TC, H-NL), Taipei Veterans General Hospital, Taipei; Department of Dermatology (C-KJ, J-LS, Y-JC), Taichung Veterans General Hospital; Institute of Biomedical Sciences (J-JS), National Chung Hsing University; and Department of Education and Research (J-JS), Taichung Veterans General Hospital, Taichung, Taiwan.
    • Medicine (Baltimore). 2016 May 1; 95 (22): e3816e3816.

    AbstractPsoriasis patients with moderate to severe disease often present with depression and insomnia. Treatment targeting both psoriasis and psychological comorbidities is needed to improve the quality of life of these patients.In this nationwide cohort study, a total of 980 patients with psoriatic arthritis or psoriasis who had received nonbiological disease-modifying antirheumatic drugs and biologics therapy between 2009 and 2012 were identified. The prevalence rates of patients taking medications for depression and insomnia were compared before and after biologics therapy. Logistic regression method was used to investigate the risk factors for depression and insomnia. Further stratified analyses were performed to examine the prevalence of use of medications for depression and insomnia among different patient subgroups.The prevalence of patients taking regular antidepressants before starting biologics therapy was about 20%. There was a more than 40% reduction in this prevalence after biologics therapy for 2 years. Age higher than 45 years, female sex, presence of comorbidities, and psoriatic arthritis were independently associated with depression and insomnia. Further stratified analyses revealed a more rapid and significant reduction in depression/insomnia in those undergoing continuous biologics therapy, younger than 45 years, without psoriatic arthritis and not taking concomitant methotrexate, when compared with their counterparts.The results suggest that biologics therapy may be associated with reduced rates of depression and insomnia, and a reduced rate of regular antidepressants use in psoriasis patients.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,624,503 articles already indexed!

We guarantee your privacy. Your email address will not be shared.